Anti-LIPF antibodies are used in the immunodetection of the protein lipase F, gastric type. In humans, the canonical protein has a reported length of 398 amino acid residues and a mass of 45.2 kDa. It has been described to be a secreted protein. Up to 4 different isoforms have been reported for this protein. It is notably expressed in the stomach. A member of the Lipase protein family, LIPF is known to catalyze the hydrolysis of triacylglycerols to yield free fatty acids, diacylglycerol, monoacylglycerol, and glycerol. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include GL and HGL. LIPF gene orthologs have been reported in the rat, bovine and chimpanzee species. Some LIPF antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.